Report Thumbnail
Product Code LP0912811473EU2
Published Date 2023/3/3
English75 PagesGlobal

Global Creatinine Test Device Market Growth 2023-2029MedicalDevice_MedTech Market


Report Thumbnail
Product Code LP0912811473EU2◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/3/3
English 75 PagesGlobal

Global Creatinine Test Device Market Growth 2023-2029MedicalDevice_MedTech Market



Abstract


Summary

The global Creatinine Test Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Creatinine Test Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Creatinine Test Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Creatinine Test Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Creatinine Test Device players cover Nova Biomedical, Siemens, Abbott and Radiometer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Since creatinine is usually measured by various biochemical analyzers using special kits, this market is difficult to count. Therefore, this report only counts POC (point of care) devices.
LPI (LP Information)' newest research report, the “Creatinine Test Device Industry Forecast” looks at past sales and reviews total world Creatinine Test Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Creatinine Test Device sales for 2023 through 2029. With Creatinine Test Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Creatinine Test Device industry.
This Insight Report provides a comprehensive analysis of the global Creatinine Test Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Creatinine Test Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Creatinine Test Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Creatinine Test Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Creatinine Test Device.
This report presents a comprehensive overview, market shares, and growth opportunities of Creatinine Test Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Creatinine Blood Test
Creatinine Urine Test
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Nova Biomedical
Siemens
Abbott
Radiometer
Key Questions Addressed in this Report
What is the 10-year outlook for the global Creatinine Test Device market?
What factors are driving Creatinine Test Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Creatinine Test Device market opportunities vary by end market size?
How does Creatinine Test Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Creatinine Test Device Annual Sales 2018-2029
      • 2.1.2 World Current & Future Analysis for Creatinine Test Device by Geographic Region, 2018, 2022 & 2029
      • 2.1.3 World Current & Future Analysis for Creatinine Test Device by Country/Region, 2018, 2022 & 2029
    • 2.2 Creatinine Test Device Segment by Type
      • 2.2.1 Creatinine Blood Test
      • 2.2.2 Creatinine Urine Test
    • 2.3 Creatinine Test Device Sales by Type
      • 2.3.1 Global Creatinine Test Device Sales Market Share by Type (2018-2023)
      • 2.3.2 Global Creatinine Test Device Revenue and Market Share by Type (2018-2023)
      • 2.3.3 Global Creatinine Test Device Sale Price by Type (2018-2023)
    • 2.4 Creatinine Test Device Segment by Application
      • 2.4.1 Hospitals
      • 2.4.2 Clinics
      • 2.4.3 Others
    • 2.5 Creatinine Test Device Sales by Application
      • 2.5.1 Global Creatinine Test Device Sale Market Share by Application (2018-2023)
      • 2.5.2 Global Creatinine Test Device Revenue and Market Share by Application (2018-2023)
      • 2.5.3 Global Creatinine Test Device Sale Price by Application (2018-2023)
  • 3 Global Creatinine Test Device by Company

    • 3.1 Global Creatinine Test Device Breakdown Data by Company
      • 3.1.1 Global Creatinine Test Device Annual Sales by Company (2018-2023)
      • 3.1.2 Global Creatinine Test Device Sales Market Share by Company (2018-2023)
    • 3.2 Global Creatinine Test Device Annual Revenue by Company (2018-2023)
      • 3.2.1 Global Creatinine Test Device Revenue by Company (2018-2023)
      • 3.2.2 Global Creatinine Test Device Revenue Market Share by Company (2018-2023)
    • 3.3 Global Creatinine Test Device Sale Price by Company
    • 3.4 Key Manufacturers Creatinine Test Device Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Creatinine Test Device Product Location Distribution
      • 3.4.2 Players Creatinine Test Device Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    • 3.6 New Products and Potential Entrants
    • 3.7 Mergers & Acquisitions, Expansion
  • 4 World Historic Review for Creatinine Test Device by Geographic Region

    • 4.1 World Historic Creatinine Test Device Market Size by Geographic Region (2018-2023)
      • 4.1.1 Global Creatinine Test Device Annual Sales by Geographic Region (2018-2023)
      • 4.1.2 Global Creatinine Test Device Annual Revenue by Geographic Region (2018-2023)
    • 4.2 World Historic Creatinine Test Device Market Size by Country/Region (2018-2023)
      • 4.2.1 Global Creatinine Test Device Annual Sales by Country/Region (2018-2023)
      • 4.2.2 Global Creatinine Test Device Annual Revenue by Country/Region (2018-2023)
    • 4.3 Americas Creatinine Test Device Sales Growth
    • 4.4 APAC Creatinine Test Device Sales Growth
    • 4.5 Europe Creatinine Test Device Sales Growth
    • 4.6 Middle East & Africa Creatinine Test Device Sales Growth
  • 5 Americas

    • 5.1 Americas Creatinine Test Device Sales by Country
      • 5.1.1 Americas Creatinine Test Device Sales by Country (2018-2023)
      • 5.1.2 Americas Creatinine Test Device Revenue by Country (2018-2023)
    • 5.2 Americas Creatinine Test Device Sales by Type
    • 5.3 Americas Creatinine Test Device Sales by Application
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Creatinine Test Device Sales by Region
      • 6.1.1 APAC Creatinine Test Device Sales by Region (2018-2023)
      • 6.1.2 APAC Creatinine Test Device Revenue by Region (2018-2023)
    • 6.2 APAC Creatinine Test Device Sales by Type
    • 6.3 APAC Creatinine Test Device Sales by Application
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Creatinine Test Device by Country
      • 7.1.1 Europe Creatinine Test Device Sales by Country (2018-2023)
      • 7.1.2 Europe Creatinine Test Device Revenue by Country (2018-2023)
    • 7.2 Europe Creatinine Test Device Sales by Type
    • 7.3 Europe Creatinine Test Device Sales by Application
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Creatinine Test Device by Country
      • 8.1.1 Middle East & Africa Creatinine Test Device Sales by Country (2018-2023)
      • 8.1.2 Middle East & Africa Creatinine Test Device Revenue by Country (2018-2023)
    • 8.2 Middle East & Africa Creatinine Test Device Sales by Type
    • 8.3 Middle East & Africa Creatinine Test Device Sales by Application
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Creatinine Test Device
    • 10.3 Manufacturing Process Analysis of Creatinine Test Device
    • 10.4 Industry Chain Structure of Creatinine Test Device
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Creatinine Test Device Distributors
    • 11.3 Creatinine Test Device Customer
  • 12 World Forecast Review for Creatinine Test Device by Geographic Region

    • 12.1 Global Creatinine Test Device Market Size Forecast by Region
      • 12.1.1 Global Creatinine Test Device Forecast by Region (2024-2029)
      • 12.1.2 Global Creatinine Test Device Annual Revenue Forecast by Region (2024-2029)
    • 12.2 Americas Forecast by Country
    • 12.3 APAC Forecast by Region
    • 12.4 Europe Forecast by Country
    • 12.5 Middle East & Africa Forecast by Country
    • 12.6 Global Creatinine Test Device Forecast by Type
    • 12.7 Global Creatinine Test Device Forecast by Application
  • 13 Key Players Analysis

    • 13.1 Nova Biomedical
      • 13.1.1 Nova Biomedical Company Information
      • 13.1.2 Nova Biomedical Creatinine Test Device Product Portfolios and Specifications
      • 13.1.3 Nova Biomedical Creatinine Test Device Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.1.4 Nova Biomedical Main Business Overview
      • 13.1.5 Nova Biomedical Latest Developments
    • 13.2 Siemens
      • 13.2.1 Siemens Company Information
      • 13.2.2 Siemens Creatinine Test Device Product Portfolios and Specifications
      • 13.2.3 Siemens Creatinine Test Device Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.2.4 Siemens Main Business Overview
      • 13.2.5 Siemens Latest Developments
    • 13.3 Abbott
      • 13.3.1 Abbott Company Information
      • 13.3.2 Abbott Creatinine Test Device Product Portfolios and Specifications
      • 13.3.3 Abbott Creatinine Test Device Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.3.4 Abbott Main Business Overview
      • 13.3.5 Abbott Latest Developments
    • 13.4 Radiometer
      • 13.4.1 Radiometer Company Information
      • 13.4.2 Radiometer Creatinine Test Device Product Portfolios and Specifications
      • 13.4.3 Radiometer Creatinine Test Device Sales, Revenue, Price and Gross Margin (2018-2023)
      • 13.4.4 Radiometer Main Business Overview
      • 13.4.5 Radiometer Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.